King-Denborough syndrome (KDS)
Written and reviewed by Dr Ibrahim Imam, Consultant Neurologist. Last reviewed .
King-Denborough syndrome (KDS). This is caused by mutations in the ryanodine receptor 1 (RYR1) gene. Fully referenced neurology checklist.
Genetics
- This is caused by mutations in the ryanodine receptor 1 (RYR1) gene
- The transmission is autosomal dominant
Clinical features
Locked: subscribe to see this section.
Dysmorphic features
Locked: subscribe to see this section.
Skeletal features
Locked: subscribe to see this section.
Muscle biopsy: features
Locked: subscribe to see this section.
Anaesthetic management
Locked: subscribe to see this section.
References
- D'Arcy CE, Bjorksten A, Yiu EM, et al. King-denborough syndrome caused by a novel mutation in the ryanodine receptor gene. Neurology 2008; 71:776-777.
- Dowling JJ, Lillis S, Amburgey K, et al. King-Denborough syndrome with and without mutations in the skeletal muscle ryanodine receptor (RYR1) gene. Neuromuscul Disord 2011; 21:420-427.
- McPherson EW, Taylor CA Jr. The King syndrome: malignant hyperthermia, myopathy, and multiple anomalies. Am J Med Genet 1981; 8:159-165.
- Reed UC, Resende MB, Ferreira LG, et al. King-Denborough syndrome: report of two Brazilian cases. Arq Neuropsiquiatr 2002; 60:739-741.
- Chitayat D, Hodgkinson KA, Ginsburg O, Dimmick J, Watters GV. King syndrome: a genetically heterogenous phenotype due to congenital myopathies. Am J Med Genet 1992; 43:954-956.
- And 2 more. Subscribe to see the full list
